Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII

About this update from Cannara Biotech, Inc.

[{"type":"text","content":"Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIIIMontreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings. Cannara Biotech Inc is scheduled to present on June 7th at 3:00 PM PT. Nicholas Sosiak, Chief Financial Officer, will be leading the presentation. We invited interested parties to register for the event here: https://ldinv13.sequireevents.com/ About Cannara Biotech IncCannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Québec and Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 120,000kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca. About LD Micro LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Whether it is the Index, comprehensive data, or hosting the most significant events annually, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies. For more information on LD Micro, visit www.ldmicro.com. To present or register, please get in touch with [email protected] To learn more about Freedom US Markets, visit www.freedomusmkts.com For further information on Cannara Biotech Inc:Nicholas SosiakChief Financial [email protected]","length":2657,"tagName":"div"}]

More updates from Cannara Biotech, Inc.